ArticlePediatric nephrology (Berlin, Germany)2025
Incidence and determinants of graft failure and death with functioning graft after re-transplantation.
Article in Pediatric nephrology (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundRecent reports on allograft survival after repeat kidney transplantation (KTx) and the incidence and determinants of graft failure (GF) are lacking.
methodsWe analyzed the probability of graft failure (GF) and death with functioning graft following a primary pediatric and sequential kidney transplantation (KTx) in 4528 primary, 1155 second, 259 third, and 41 fourth KTx. We calculated the impact of relevant peri-transplant characteristics on the probability of GF and death with functioning graft (as a composite endpoint due to statistical reasons) for specific recipient profiles.
resultsThe respective unadjusted 5-year GF probabilities after first, second, third, and fourth KTx were 15%, 24%, 30%, and 40%, respectively (P < 0.001). The adjusted hazard ratio for the composite endpoint was the highest in the first month after primary transplantation and even higher after subsequent transplantations. After second KTx, older year of transplantation, deceased donor (DD), older donor age, short primary graft survival, PRA 1-100%, and increasing HLA-DR mismatches were associated with a higher predicted outcome. The respective predicted 5-year risks for the outcome in a pediatric DD KTx recipient with 0 and 2 HLA-DR mismatches were 17% and 27% with a 30-year-old DD and 22% and 35% with a 50-year-old DD.
conclusionsGF increased with subsequent KTx. GF and death with a functioning graft after second transplantation improved with calendar year of transplantation, reflecting improvements in transplant care over time. Older donor age, DD KTx, short primary graft survival, high PRA, and increasing HLA-DR mismatch were associated with a higher predicted composite outcome.
Indexed as
Identifiers
40775406What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.